HighTower Advisors’s Bioverativ Inc. Common Stock BIVV Stock Holding History

HighTower Advisors’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-7,816	Closed	-$430K	–	2413
2017 Q4	$430K	Sell	7,816 -17,300	-69%	-$947K	﹤0.01%	1515
2017 Q3	$1.44M	Sell	25,116 -943	-4%	-$55.2K	0.01%	943
2017 Q2	$1.58M	Buy	26,059 +14,231	+120%	+$810K	0.01%	891
2017 Q1	$624K	Buy	+11,828	New	+$583K	0.01%	1230

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

HighTower Advisors's BIVV Position: Q1 2018 in Review

HighTower Advisors sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 7,816 shares — an estimated $430K sold.

HighTower Advisors first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $1.58M in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

HighTower Advisors reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
HighTower Advisors sold 7,816 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $430K.
HighTower Advisors first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
HighTower Advisors's Bioverativ Inc. Common Stock position peaked at $1.58M in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on HighTower Advisors's 13F filing for Q1 2018, filed 15 May 2018.